Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DOK5 |
| Upstream (Parents) |
|---|
| (<<) COL6A2 → DOK5 |
| (<<) LOXL1 → DOK5 |
| (<<) SPARC → DOK5 |
| Downstream (Children) |
|---|
| DOK5 → GLI1 (>>) |
| DOK5 → CD34 (>>) |
| DOK5 → GPR183 (>>) |
| DOK5 → TP53TG3B///TP53TG3 (>>) |
| DOK5 → TRO (>>) |
| DOK5 → PNMAL1 (>>) |
| DOK5 → SLC19A1 (>>) |
| DOK5 → NUP188 (>>) |
| DOK5 → C6orf25 (>>) |
| DOK5 → HAB1 (>>) |
| DOK5 → VEGFC (>>) |
